Drugs or drug delivery systems, which are approved and/or under phase trials.
Published in Chapter:
Implementation of Nanoparticles in Cancer Therapy
Ece Bayir (Ege University, Turkey), Eyup Bilgi (Ege University, Turkey), and Aylin Sendemir Urkmez (Ege University, Turkey)
Copyright: © 2014
|Pages: 45
DOI: 10.4018/978-1-4666-5824-0.ch018
Abstract
Cancer is a wide group of diseases and generally characterized by uncontrolled proliferation of cells whose metabolic activities are disrupted. Conventionally, chemotherapy, radiotherapy, and surgery are used in the treatment of cancer. However, in theory, even a single cancer cell may trigger recurrence. Therefore, these treatments cannot provide high survival rate for deadly types. Identification of alternative methods in treatment of cancers is inevitable because of adverse effects of conventional methods. In the last few decades, nanotechnology developed by scientists working in different disciplines—physics, chemistry, and biology—offers great opportunities. It is providing elimination of both circulating tumor cells and solid cancer cells by targeting cancer cells. In this chapter, inadequate parts of conventional treatment methods, nanoparticle types used in new treatment methods of cancer, and targeting methods of nanoparticles are summarized; furthermore, recommendations of future are provided.